Sun, Aug 25 5:29am

Compare INVA



Innoviva Inc [INVA]
$11.08 0.32 (2.81%)

INVA Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 1.12 Billion
INVA Description

Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline.


Visit Website

INVA Earnings

EPS 0.37 P/E Ratio 3.94
Previous Earnings Wed, May 1, 2019
Latest Earnings Wed, Jul 24, 2019 (32 days ago) -16.06%

INVA Dividend

Yield --
Ex-Date --
Pay Date --
History 5 Payments (Quarterly)

INVA Charts

$11.05
1 Year
$20.24
Aug 23, 2019
Jan 29, 2019



Symbol Price Day % YTD %
INVA $11.08 -2.81% -35.95%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy